Computational analysis of the functional impact of MHC-II-expressing triple-negative breast cancer
The tumor microenvironment (TME) plays a crucial role in tumor progression and immunoregulation. Major histocompatibility complex class II (MHC-II) is essential for immune surveillance within the TME. While MHC-II genes are typically expressed by professional antigen-presenting cells, they are also...
Saved in:
| Main Authors: | Yang Cui, Weihang Zhang, Xin Zeng, Yitao Yang, Sung-Joon Park, Kenta Nakai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1497251/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Specific targeting of MHC antigens for T-cells and immune cells in human disease
by: Ali Afzal, et al.
Published: (2025-01-01) -
OnmiMHC: a machine learning solution for UCEC tumor vaccine development through enhanced peptide-MHC binding prediction
by: Fangfang Jian, et al.
Published: (2025-02-01) -
Using major histocompatibility complex (MHC) II expression to predict antitumor response to CD4 + lymphocyte depletion
by: Yanping Wang, et al.
Published: (2025-02-01) -
Tumor-specific MHC-II guides anthracycline exemption and immunotherapy benefit in breast cancer
by: Zehao Wang, et al.
Published: (2025-06-01) -
Decoding MHC loss: Molecular mechanisms and implications for immune resistance in cancer
by: Pei Lin, et al.
Published: (2025-07-01)